FDA Urges 2nd Screening for Fla. Women
242827
The Food and Drug Administration is advising women who recently received mammograms at Ecumed Health Group in Hialeah, Fla., to seek another screening or an independent review of past film to ensure breast cancer warnings weren't missed.
372828
An advisory panel to the Food and Drug Administration will meet today to decide whether a skin patch to heighten the sexual arousal of older women is safe and effective and should be licensed as a new drug.
331062
The warning concerns work done by Ecumed Health Group in Hialeah. The women are being told to seek another screening or an independent review of past film to ensure breast cancer warnings.
610520
The Food and Drug Administration will add additional warnings to RU-48, the so-called &#39;morning after pill&#39; after the death of an 18 year-old California woman last year.
404075
New evidence is raising questions about the tests used to prescribe the breast cancer drug Herceptin, which was initially seen as a model for tailored medicine.
552052
U.S. health officials issued the second warning since 2005 on Friday about deaths from misuse of Johnson & Johnson's Duragesic pain-killing patch or generic versions.
368066
The US drug agency agreed to allow a drug currently used against advanced breast cancer to be prescribed to prevent the disease from recurring in women who have been treated for early forms of the disease.
68174
The US Food and Drug Administration announced Tuesday that it has set up a national registry to follow women of childbearing age who are prescribed the acne drug Accutane
300930
Amidst reports of another young woman&#39;s death related to an FDA-approved abortion pill, pro-lifers are again calling for the drug to be pulled from the market.
174423
A test currently available on the market can predict which breast cancer patients are at risk for their cancer to recur, which could be a vital tool for deciding if further treatment, such as chemotherapy will be useful or safely avoided.
393500
FRIDAY, Dec. 15 (HealthDay News) -- U.S. researchers have developed two genomic tests to help doctors better predict how breast cancer patients will respond to hormonal therapy or chemotherapy.
242819
The Food and Drug Administration remains on the defensive. The agency got grilled on Capitol Hill for the second day in a row about the health risks of several popular prescription drugs.
344220
More U.S. women are taking daily supplements of folic acid, a B vitamin crucial to prevent some major birth defects, but the number remains too low, federal health officials said on Thursday.
103166
WASHINGTON Dec 2, 2004 - A hormone patch that works to restore a woman&#39;s sex drive should not be approved until additional studies to determine its risk, federal health advisers said Thursday.
606616
Responding to continuing criticism about its warning policies, the Food and Drug Administration said Friday it will strengthen its system for reviewing the safety of drugs already on the market.
663048
Public health officials are now encouraging women to make sure they are in optimal health well in advance of a pregnancy.
530863
The US Food and Drug Administration (FDA) approved a new genetic test of the likelihood of recurring breast cancer, five to ten years after its onset.